The International Neurological Biomarkers market size was xxx million USD with a CAGR xx % from 2015- 2019. It will stretch to xxx million USD in 2020 with a CAGR of xx % from 2020 to 2025.
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
The classification of Neurological Biomarkers includes Proteomics, Genomics, Imaging, Bioinformatics and others, and the proportion of Proteomics in 2017 is about 31%.
Neurological Biomarkers is widely used in Diagnostics, Drug Discovery, Personalized Medicine and other field. The most proportion of Neurological Biomarkers is used for Diagnostics, and the revenue in 2017 is 1.35 billion USD.
North America is the largest consumption place, with a consumption market share nearly 57% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
As the report focuses on global Neurological Biomarkers market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
In market segmentation by manufacturers, the report covers the following companies-
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
In market segmentation by geographical regions, the report has analyzed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In market segmentation by types covers:
Proteomics
Genomics
Imaging
Bioinformatics
Others
In market segmentation by applications :
Diagnostics
Drug Discovery
Personalized Medicine
Others
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Neurological Biomarkers market for the forecast period 2020 - 2025?
• What are the driving forces in the Neurological Biomarkers market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Neurological Biomarkers industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?